Author: Paul Govern

Benoit Dawant, PhD, left, Erik Tkaczyk, MD, PhD, and colleagues have developed a new way to measure human monkeypox severity.

Vanderbilt study uses AI to speed monkeypox drug trials

Sep. 22, 2022—A machine learning algorithm developed by researchers at Vanderbilt performs as well as humans at identifying skin lesions in clinical photographs of people with monkeypox.

VUMC to lead AI ethics core for NIH project

Sep. 22, 2022—Vanderbilt researchers will lead and comprise the greater part of an artificial intelligence research ethics core for a National Institutes of Health (NIH) program called Bridge to Artificial Intelligence, or Bridge2AI.

Policy experts discuss abortion ruling and health data privacy

Sep. 22, 2022—Vanderbilt policy experts discuss how the recent U.S. Supreme Court decision overturning Roe v. Wade and newly enacted state laws limiting or banning abortion can be expected to bring new scrutiny to the privacy vulnerabilities of electronic health records.

Lisa Shadrick, who participated in Vanderbilt’s MyMaternityHealth bundle program, is a tutor employed by Metro Nashville Public Schools. Here, she is holding her newborn son, Jameson.

Maternity care bundled payment model recognized

Sep. 1, 2022—Vanderbilt Health’s bundled payment model for maternity care, MyMaternityHealth, is among 14 initiatives recognized as KLAS Points of Light 2022 by KLAS Research.

An initiative at VUMC is helping patients recover more quickly from major surgery, leave the hospital earlier and have fewer side effects from their pain management.

VUMC launches enhanced recovery for total joint replacement

Aug. 17, 2022—Vanderbilt's enhanced recovery after surgery (ERAS) program recently expanded to include the 1,400 patients per year who receive total hip replacement or total knee replacement surgery.

Study explores clinical uses for polygenic risk scores

Jul. 14, 2022—Vanderbilt University Medical Center has received a five-year, $4.5 million grant from the National Human Genome Research Institute to assess clinical outcomes and economic value of screening large, diverse health care populations for disease risk using polygenic risk scores.

A speedier treatment for depression?

Jul. 11, 2022—Vanderbilt researchers used a computer-based search to identify a compound with promise as a new, mechanistically distinct and rapid-acting therapy for major depressive disorder.

Professionalism and patient outcomes

Jul. 7, 2022—A study of more than 70,000 trauma patients found that those who received care from a service with a high proportion of physicians modeling unprofessional behavior were at a 24% increased risk of death or complications.

Ward honored by National Psoriasis Foundation

Jul. 7, 2022—Vanderbilt's Nicole Ward, PhD, was one of three honorees who were the focus of attention at the National Psoriasis Foundation’s 2022 Commit to Cure Gala: Celebrating Women Who Lead, held recently in Chicago.

Horst, Patterson receive Physician Builder Awards

Jun. 16, 2022—Sara Horst, MD, MPH, associate professor of Medicine, and Barron Patterson, MD, associate professor of Pediatrics, have received 2022 Physician Builder Awards.

Epidemic Intelligence Service officers check the humidity and take samples from linens in a patient room while investigating a hospital-associated mucormycosis outbreak in Little Rock, Arkansas, in March 2021.

VUMC to pilot CDC joint training program

Jun. 16, 2022—Vanderbilt University Medical Center is among 11 centers that will pilot a new federally sponsored training program, the Joint Infectious Diseases/Epidemic Intelligence Service (ID/EIS) Fellowship.

Researchers add sign language videos to electronic surveys

Jun. 16, 2022—A new external module in Vanderbilt's REDCap improves electronic survey accessibility for respondents who are deaf. The module makes it easy to embed individual sign language videos for each survey question and answer.